Salt-inducible kinase 2 regulates fibrosis during bleomycin-induced lung injury

Idiopathic pulmonary fibrosis is a progressive and normally fatal disease with limited treatment options. The tyrosine kinase inhibitor nintedanib has recently been approved for the treatment of idiopathic pulmonary fibrosis, and its effectiveness has been linked to its ability to inhibit a number o...

Descripción completa

Detalles Bibliográficos
Autores principales: van Gijsel-Bonnello, Manuel, Darling, Nicola J., Tanaka, Takashi, Di Carmine, Samuele, Marchesi, Francesco, Thomson, Sarah, Clark, Kristopher, Kurowska-Stolarska, Mariola, McSorley, Henry J., Cohen, Philip, Arthur, J. Simon C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706632/
https://www.ncbi.nlm.nih.gov/pubmed/36309093
http://dx.doi.org/10.1016/j.jbc.2022.102644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706632/
https://www.ncbi.nlm.nih.gov/pubmed/36309093
http://dx.doi.org/10.1016/j.jbc.2022.102644

Ejemplares similares